Bio Pharma Dive

NOVEMBER 7, 2022

Buoyed by strong mid-stage study results, the biotech will soon start a cardiovascular outcomes trial of a drug designed to target a genetic risk factor called lipoprotein(a).

Drug Trials 291

Drug Trials Trials Drugs Genetics 291

pharmaphorum

MAY 19, 2022

.” Empatica’s range of wearables are well-established tools for studies in the pharma and healthcare industry, and have been used by many drug and medical device developers, including Sanofi, Roche, Novartis, Abbott, Bristol-Myers Squibb, and Johnson & Johnson.

Drug Trials 105

Drug Trials Trials Drugs Development 105

Bio Pharma Dive

DECEMBER 6, 2022

The decision not to run a Phase 3 trial of their medicine is the latest fallout from U.S. regulators’ recent moves to closely evaluate a class of drugs known as PI3 kinase inhibitors.

Drug Trials 164

Drug Trials Trials Drugs Medicine 164

Drug Discovery World

MARCH 29, 2023

The post First patient dosed in ulcerative colitis drug trial appeared first on Drug Discovery World (DDW). This is measured by changes in laboratory values including C-reactive protein and faecal calprotectin, and changes in validated clinical and endoscopic scoring systems.

Drug Trials 52

Drug Trials Trials Drugs Clinical Trials 52

Bio Pharma Dive

JULY 17, 2023

The results come about two years after negative findings from an earlier phase of the study, and position the company to seek an approval in transthyretin amyloidosis cardiomyopathy.

Drug Trials 130

Drug Trials Trials Drugs 130

Bio Pharma Dive

AUGUST 23, 2021

The decision, which follows the recommendation of a data monitoring committee, is yet another setback in the search for more treatments for the neurological disease.

Drug Trials 260

Drug Trials Trials Drugs 260

Bio Pharma Dive

OCTOBER 31, 2022

Bringing more diversity to clinical trials is a slow process and it takes time to get right. Learn how Worldwide Clinical Trials can diversify the reach of your orphan drug trial.

Clinical Trials 319

Clinical Trials Clinical Trials Drug Trials Trials 319

Bio Pharma Dive

MAY 24, 2022

The biotech plans to seek FDA approval for its soft-tissue tumor treatment after positive study results. But investors still sent the stock down by nearly 10%.

Drug Trials 130

Drug Trials FDA Approval Trials Drugs 130

Bio Pharma Dive

JULY 28, 2022

Important data from the APOLLO study of the biotech's drug Onpattro are due before the end of August, Alnylam said Thursday.

Drug Trials 173

Drug Trials Drugs Trials 173

Bio Pharma Dive

JANUARY 10, 2023

Moderna’s Stéphane Bancel and Pfizer’s Albert Bourla hinted Monday at greater dealmaking to come for their companies, while Gilead gave investors an update on an important cancer drug trial.

Trials 289

Trials Drug Trials Vaccination Vaccine 289

pharmaphorum

JANUARY 25, 2021

Data in second line was “robust” and merits further trials, the company said in an update earlier this month, and the company is continuing to gather data from a part of the study testing the drug in first line NSCLC. The post GSK suffers another R&D setback, axing ulcerative colitis drug trial appeared first on.

Drug Trials 103

Drug Trials Trials Drugs Antibody 103

pharmaphorum

OCTOBER 27, 2020

Merimepodib is the subsidiary’s primary asset, and the biotech now says it is to offers to acquire or license the drug. The post BioSig abandons COVID-19 drug trial on safety concerns appeared first on. Image credit: Rocky Mountain Labs/NIH.

Drug Trials 98

Drug Trials Trials Drugs RNA 98

pharmaphorum

MAY 7, 2021

The post Small Pharma stock market launch funds DMT-based depression drug trial appeared first on. “Given most other psychedelics focused companies have only been formed in the last 2 years, we believe our focus on IP since inception in 2015 gives us the potential to build a robust portfolio of valuable assets,” he added.

Drug Trials 98

Drug Trials Drugs Trials Clinical Trials 98

BioPharma Reporter

JULY 4, 2023

Sosei Heptares has dosed the first subject in a phase 1 trial evaluating HTLâ149, a first-in-class GPR52 agonist, which represents a novel mechanism of action for the treatment of schizophrenia and related neurological diseases.

Drug Trials 78

Drug Trials Trials Drugs Development 78

Drug Discovery World

FEBRUARY 20, 2023

While changes to how clinical trials are conducted and trial data is managed are likely in 2023 and going forward, and we can expect less attention on Covid-19, it is a safe bet that oncology will remain an area of focus for many companies. The post What are the top disease areas for clinical drug trials?

Drug Trials 52

Drug Trials Trials Clinical Trials Clinical Trials 52

BioPharma Reporter

OCTOBER 4, 2022

Kibow Biotech is celebrating its 25th anniversary as the company pivots toward developing a drug based on its proprietary probiotic strains that benefit kidney disease suffers.

Drug Trials 98

Drug Trials Drugs Trials Development 98

STAT News

MARCH 29, 2023

Lupus is a disease long-plagued by failed clinical trials. And hopeful patients, many of them young women of color, are waiting — just three lupus drugs have been approved by the Food and Drug Administration in six decades. A key partnership is looking to change that.  

Drug Trials 116

Drug Trials Drugs Trials Clinical Trials 116

pharmaphorum

MAY 14, 2021

The post Scepticism in press over Kintor’s COVID-19 US drug trial appeared first on. But one of the study’s authors, Brown University dermatology professor Carlos Wambler, dismissed critics and called findings “very encouraging”.

Drug Trials 52

Drug Trials Trials Drugs Dermatology 52

Medical Xpress

DECEMBER 29, 2022

A new drug designed to ward off Alzheimer's is being tested at more than 100 sites around the world, including the University of Pennsylvania.

Drug Trials 89

Drug Trials Drugs Trials Research 89

Outsourcing Pharma

APRIL 6, 2023

TWO US clinical investigator sites have been opened for a phase 1 clinical trial for patients with soft tissue sarcoma and the first patient has been dosed.

Drug Trials 98

Drug Trials Trials Clinical Trials Clinical Trials 98

STAT News

FEBRUARY 17, 2023

Pfizer and partner Valneva are scrapping data from roughly half of the participants in a Phase 3 trial of a Lyme disease vaccine candidate after uncovering quality issues with a third-party clinical trial operator.

Trials 119

Trials Drug Trials Clinical Trials Clinical Trials 119

Scienmag

JANUARY 19, 2022

New research suggests manufacturers of newly developed antidepressant drugs have become more forthcoming about clinical trials that don’t pan out.

Trials 83

Trials Drug Trials Drugs Clinical Trials 83

BioSpace

FEBRUARY 15, 2021

According to a statement made by Cortexyme, the partial hold was placed on the development program for atuzaginstat after an FDA review of the trial data identified hepatic adverse events.

Drug Trials 103

Drug Trials Trials Drugs Development 103

pharmaphorum

AUGUST 6, 2020

The post Lundbeck gets cold feet, axes schizophrenia drug trial appeared first on.

Drug Trials 52

Drug Trials Trials Drugs Medicine 52

Pharma Times

DECEMBER 4, 2020

LYT-100 will be evaluated in patients with persistent symptoms caused by COVID-19

Drug Trials 114

Drug Trials Trials Drugs 114

Scienmag

DECEMBER 20, 2021

A clinical trial in which two test drugs failed to help patients with mild COVID-19 nevertheless had a silver lining: It proved the viability of a study model in which a medication’s potential arrhythmic side effects are safely, effectively monitored without the participants ever setting foot in a hospital or clinic.

Drug Trials 79

Drug Trials Trials Drugs Clinical Trials 79

BioTech 365

JULY 19, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Troubled Cytokinetics’ stock soars as gets much needed phase 2 heart drug trial win, plans late-stage effort by year’s end.Troubled Cytokinetics’ stock soars as gets much needed … Continue reading →

Drug Trials 40

Drug Trials Trials Drugs Research 40

Outsourcing Pharma

JANUARY 16, 2023

A Florida doctor has been sent to prison after submitting a false affidavit claiming she had screened children in a clinical study looking at the effectiveness of drugs given to children with asthma when she had not.

Drug Trials 59

Drug Trials Drugs Trials Doctors 59

BioSpace

MARCH 22, 2021

Ionis Pharmaceuticals announced that its collaboration partner, Roche, was discontinuing dosing in the Phase III GENERATION HD1 trial of tominersen in manifest Huntington’s disease (HD).

Drug Trials 77

Drug Trials Trials Drugs 77

Outsourcing Pharma

AUGUST 29, 2022

The company reports dosing of the first subject in a Phase IIa proof-of-concept study investigating a drug for an autism spectrum disorder related condition.

Drug Trials 52

Drug Trials Drugs Trials Drug Delivery 52

BioTech 365

JUNE 17, 2021

Global Mantle Cell Lymphoma Clinical Landscape Market Report 2021: Marketed and Pipeline Drugs, Trials, Key Events, Success Probability, 10-Year Disease Prevalence Forecast, Deals, Revenue Forecasts – ResearchAndMarkets.com Global Mantle Cell Lymphoma Clinical Landscape Market Report 2021: Marketed and Pipeline Drugs, … Continue reading (..)

Drug Trials 40

Drug Trials Drugs Trials Marketing 40

STAT News

SEPTEMBER 22, 2022

Hello, everyone, and how are you today? A dank cloudy cover greeted us this morning, but we are ignoring the gloom by keeping busy. After all, there is much to be done. There are deadlines to meet, a variety of reading material to digest, and calls to make. We trust you can relate.

Drug Trials 98

Drug Trials Trials Drugs 98

BioSpace

OCTOBER 11, 2020

was convicted on 47 counts of fraud and drug related charges on Oct. A 41-year-old man from Richland, Wash. 1, according to the U.S. Justice Department’s Eastern District of Washington.

Drug Trials 110

Drug Trials Drugs Trials 110

STAT News

MARCH 27, 2023

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of online meetings, phone calls, and deadlines has predictably returned. But you knew this would happen, yes? After all, the world, such as it is, keeps spinning.

Trials 98

Trials Drugs Drug Trials Clinical Trials 98

Drug Discovery World

NOVEMBER 29, 2023

“The most important benefit is that we now have an accurate model that we can use to perform virtual experiments with different types of interventions, quickly and digitally.”

Drugs 52

Drugs Development Drug Trials FDA Approval 52

Scienmag

JUNE 15, 2022

A novel staging framework that assesses the progression of Huntington’s disease (HD), similar to the way cancer is staged 0 to 4, has been developed by UCL scientists as part of an international consortium; this ‘significant’ step paves the way for clinical trials of drugs in the earliest phase of disease.

Drug Trials 59

Drug Trials Trials Drugs Clinical Trials 59

BioSpace

JANUARY 28, 2021

Food and Drug Administration (FDA) has cleared an Investigational New Drug application that will allow Boston-based Vertex Pharmaceuticals to proceed with a clinical trial of its investigational stem cell-derived, fully differentiated pancreatic islet cell treatment for type 1 diabetes (.

Drug Trials 110

Drug Trials Drugs Trials Clinical Trials 110